PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality

PARP抑制剂在ARID1A突变型卵巢透明细胞癌治疗中的应用：PI3K/Akt1依赖性合成致死机制